1. |
Schunemann HJ, et al. Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations. Cmaj, 2003, 169(7): p. 677–680.
|
2. |
Atkins D, et al. Grading quality of evidence and strength of recommendations. Bmj, 2004, 328(7454): p. 1490.
|
3. |
Guyatt G, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest, 2006, 129(1): p. 174–181.
|
4. |
Schunemann HJ, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med, 2006, 174(5): p. 605–614.
|
5. |
Warkentin TE and A. Greinacher, Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 311S–337S.
|
6. |
Clagett GP, et al. Antithrombotic therapy in peripheral arterial occlusive disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126(3 Suppl): p. 609S–626S.
|
7. |
Bhandari M, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Cmaj, 2004, 170(4): p. 477–480.
|
8. |
Alonso-Coello P, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg, 2006, 93(8): p. 909–920.
|
9. |
Devereaux PJ, et al. A systematic review and meta-analysis of studies comparing mortality rates of private for-profit and private not-for-profit hospitals. Cmaj, 2002, 166(11): p. 1399–1406.
|
10. |
Charles C., T. Whelan, and A. Gafni, What do we mean by partnership in making decisions about treatment? Bmj, 1999, 319(7212): p. 780–782.
|
11. |
van Walraven, C., et al., Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. Jama, 2002, 288(19): p. 2441–2448.
|
12. |
Devereaux, P.A., DR. Gardner, MJ. Putnam, W. Flowerdew, GJ. Brownell, BF. Nagpal, S. Cox, JL., Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Bmj, 2001, 323(7323): p. 1218–1222.
|
13. |
CAPRIE-Steering-Committee, A randomized, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events. Lancet, 1996. 348: p. 1329–1339.
|